Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gan & Lee Insulin Glargine vs Lantus in T2DM
NCT03371108Phase 3Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Oct 2017
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Gan & Lee Pharmaceuticals. Started Oct 2017; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03371108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371108.